Department of Medicine

April 14, 2016

Switching breast cancer off

Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.

By Marilyn Holt
April 5, 2016

Immune defenses in asthma

Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.

By Leigh MacMillan
DNA sequence visualization
April 4, 2016

VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.

By Bill Snyder
March 31, 2016

Vanderbilt Asthma, Sinus, Allergy Program sees uptick in alpha-gal syndrome

Vanderbilt’s Asthma, Sinus, and Allergy Program has seen an increase in the number of patients being treated for alpha-gal syndrome, commonly known as the red meat allergy linked to tick bites.
March 31, 2016

Powers receives award from Nutrition and Dietetics association

James Powers, M.D., associate professor of Medicine and chief of Geriatric Medicine at the Veteran Affairs Medical Center, was recently named to receive the Iris Award from the Nashville Academy of Nutrition and Dietetics.

By VUMC News and Communications
March 24, 2016

Singer’s concert honors care received at Cancer Center

A cancer patient’s gratitude toward his Vanderbilt-Ingram Cancer Center (VICC) physician led to a star-studded concert to benefit the Cancer Center.

By VUMC News and Communications
March 23, 2016

Readmission prediction face-off

Using patients’ health records to assess preparedness for hospital discharge is more effective at predicting readmission or death than commonly used questionnaires.
By Paul Govern
March 17, 2016

One Million Strong event to raise awareness about colorectal cancer

Thousands of colorectal patients, families and supporters will gather in Nashville April 1 and 2 for the annual One Million Strong event to raise awareness about colorectal cancer.
By VUMC News and Communications
March 3, 2016

Melanoma response to immune therapy

Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy.
By Leigh MacMillan
March 3, 2016

Department of Medicine Mini-Research Retreat is March 12

The Department of Medicine's Mini-Research Retreat is Saturday, March 12, from 8 a.m. until noon in Light Hall 208.
By VUMC News and Communications
March 3, 2016

First VICC cancer patient treated with new immunotherapy

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.
By VUMC News and Communications
March 3, 2016

Study finds health literacy efforts ease readmission rates

Vanderbilt University Medical Center and Brigham and Women’s Hospital in Boston recently collaborated on a study analysis to determine the effect of a tailored, pharmacist-delivered health literacy intervention on unplanned hospital readmission or emergency department visit following discharge.
By Kathy Whitney
February 25, 2016

Grant bolsters rheumatoid arthritis research

C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.
By Bill Snyder
1 … 94 95 96 97 98 … 124